SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-065185
Filing Date
2023-11-20
Accepted
2023-11-20 17:08:11
Documents
12
Period of Report
2023-11-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K bttx-20231117.htm   iXBRL 8-K 37818
  Complete submission text file 0000950170-23-065185.txt   157900

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bttx-20231117_lab.xml EX-101.LAB 13896
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bttx-20231117.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bttx-20231117_pre.xml EX-101.PRE 10230
6 EXTRACTED XBRL INSTANCE DOCUMENT bttx-20231117_htm.xml XML 4860
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 231423544
SIC: 8000 Services-Health Services